1-3 of 3
Sandro Santagata
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution

Ajit J. Nirmal, Zoltan Maliga, Tuulia Vallius, Brian Quattrochi, Alyce A. Chen, Connor A. Jacobson, Roxanne J. Pelletier, Clarence Yapp, Raquel Arias-Camison, Yu-An Chen, Christine G. Lian, George F. Murphy, Sandro Santagata, Peter K. Sorger
Journal: Cancer Discovery
Cancer Discov (2022) 12 (6): 1518–1541.
https://doi.org/10.1158/2159-8290.CD-21-1357
Published: 02 June 2022
View article titled, The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution
Open the PDF for The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution in another window
Includes: Multimedia, Supplementary data
Journal Articles

Identification and Therapeutic Targeting of GPR20, Selectively Expressed in Gastrointestinal Stromal Tumors, with DS-6157a, a First-in-Class Antibody–Drug Conjugate

Kenji Iida, Amr H. Abdelhamid Ahmed, Akiko Kawano Nagatsuma, Tomoko Shibutani, Satoru Yasuda, Michiko Kitamura, Chiharu Hattori, Manabu Abe, Jun Hasegawa, Takuma Iguchi, Tsuyoshi Karibe, Takashi Nakada, Koichiro Inaki, Reiko Kamei, Yuki Abe, Taisei Nomura, Jessica L. Andersen, Sandro Santagata, Matthew L. Hemming, Suzanne George, Toshihiko Doi, Atsushi Ochiai, George D. Demetri, Toshinori Agatsuma
Journal: Cancer Discovery
Cancer Discov (2021) 11 (6): 1508–1523.
https://doi.org/10.1158/2159-8290.CD-20-1434
Published: 01 June 2021
View article titled, Identification and Therapeutic Targeting of GPR20, Selectively Expressed in Gastrointestinal Stromal Tumors, with DS-6157a, a First-in-Class Antibody–Drug Conjugate
Open the PDF for Identification and Therapeutic Targeting of GPR20, Selectively Expressed in Gastrointestinal Stromal Tumors, with DS-6157a, a First-in-Class Antibody–Drug Conjugate in another window
Includes: Supplementary data
Journal Articles

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

Priscilla K. Brastianos, Scott L. Carter, Sandro Santagata, Daniel P. Cahill, Amaro Taylor-Weiner, Robert T. Jones, Eliezer M. Van Allen, Michael S. Lawrence, Peleg M. Horowitz, Kristian Cibulskis, Keith L. Ligon, Josep Tabernero, Joan Seoane, Elena Martinez-Saez, William T. Curry, Ian F. Dunn, Sun Ha Paek, Sung-Hye Park, Aaron McKenna, Aaron Chevalier, Mara Rosenberg, Frederick G. Barker, II, Corey M. Gill, Paul Van Hummelen, Aaron R. Thorner, Bruce E. Johnson, Mai P. Hoang, Toni K. Choueiri, Sabina Signoretti, Carrie Sougnez, Michael S. Rabin, Nancy U. Lin, Eric P. Winer, Anat Stemmer-Rachamimov, Matthew Meyerson, Levi Garraway, Stacey Gabriel, Eric S. Lander, Rameen Beroukhim, Tracy T. Batchelor, José Baselga, David N. Louis, Gad Getz, William C. Hahn
Journal: Cancer Discovery
Cancer Discov (2015) 5 (11): 1164–1177.
https://doi.org/10.1158/2159-8290.CD-15-0369
Published: 01 November 2015
View article titled, Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Open the PDF for Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets in another window
Includes: Supplementary data